SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
LigoCyte Pharmaceuticals, Inc. Announces Collaboration With Biogen Idec, Inc. (Massachusetts) to Develop Anti-CD103 Therapies